An over-the-counter medication sold today as Zantac 360 by Sanofi has a different active ... Customers are turning away from the coffee giant, and its new chief executive, Brian Niccol, has ...
Zantac 360 Famotidine may also be used for purposes not listed in this medication guide. Heartburn can feel like a heart attack. chest pain that spreads to your jaw or shoulder. Get emergency ...
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.
McLaren drivers Lando Norris and Oscar Piastri were shoo-ins to be Formula 1’s next new race winners, and they duly delivered this year in Miami and Hungary respectively, becoming victors 114 ...
Corrects headline to say 'settlements' instead of 'settlement' British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits ...
Commissions do not affect our editors' opinions or evaluations. A 360 employee review gives companies a way to collect feedback from all sides—therefore the name. Of course, gathering reviews ...
A drug currently sold under the name Zantac 360 uses a different active ingredient and contains no ranitidine.
GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...
(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now ...
GSK’s American depositary receipts rose as much as 9.9% in New York after the agreement was announced. GSK is among a number of companies that made and sold versions of Zantac, and investor ...